314 related articles for article (PubMed ID: 25165026)
1. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy.
Prince HE; Lapé-Nixon M
Clin Vaccine Immunol; 2014 Oct; 21(10):1377-84. PubMed ID: 25165026
[TBL] [Abstract][Full Text] [Related]
2. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
Dollard SC; Staras SA; Amin MM; Schmid DS; Cannon MJ
Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
[TBL] [Abstract][Full Text] [Related]
3. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
[TBL] [Abstract][Full Text] [Related]
4. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
5. Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test.
Seo S; Cho Y; Park J
Korean J Lab Med; 2009 Dec; 29(6):557-62. PubMed ID: 20046088
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
[TBL] [Abstract][Full Text] [Related]
8. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
Prince HE; Leber AL
Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
[TBL] [Abstract][Full Text] [Related]
9. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women.
Grangeot-Keros L; Mayaux MJ; Lebon P; Freymuth F; Eugene G; Stricker R; Dussaix E
J Infect Dis; 1997 Apr; 175(4):944-6. PubMed ID: 9086155
[TBL] [Abstract][Full Text] [Related]
10. Combination of line immunoassays Mikrogen recomLine CMV IgG and recomLine CMV IgG Avidity helps to date the onset of CMV primary infection.
Delforge ML; Eykmans J; Steensels D; Costa E; Donner C; Montesinos I
Diagn Microbiol Infect Dis; 2019 Mar; 93(3):208-212. PubMed ID: 30361044
[TBL] [Abstract][Full Text] [Related]
11. The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus.
Lumley S; Patel M; Griffiths PD
J Med Virol; 2014 May; 86(5):834-7. PubMed ID: 24395084
[TBL] [Abstract][Full Text] [Related]
12. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing.
Kamel N; Metwally L; Gomaa N; Sayed Ahmed WA; Lotfi M; Younis S
Med Princ Pract; 2014; 23(1):29-33. PubMed ID: 24052007
[TBL] [Abstract][Full Text] [Related]
13. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
[TBL] [Abstract][Full Text] [Related]
14. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus.
Lazzarotto T; Varani S; Spezzacatena P; Gabrielli L; Pradelli P; Guerra B; Landini MP
Viral Immunol; 2000; 13(1):137-41. PubMed ID: 10733175
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation.
Vauloup-Fellous C; Berth M; Heskia F; Dugua JM; Grangeot-Keros L
J Clin Virol; 2013 Feb; 56(2):118-23. PubMed ID: 23182774
[TBL] [Abstract][Full Text] [Related]
16. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection.
Sonoyama A; Ebina Y; Morioka I; Tanimura K; Morizane M; Tairaku S; Minematsu T; Inoue N; Yamada H
J Med Virol; 2012 Dec; 84(12):1928-33. PubMed ID: 23080498
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
Lagrou K; Bodeus M; Van Ranst M; Goubau P
J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of the Roche Elecsys CMV IgG Avidity assay.
Vauloup-Fellous C; Lazzarotto T; Revello MG; Grangeot-Keros L
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1365-9. PubMed ID: 24584693
[TBL] [Abstract][Full Text] [Related]
19. Universal Screening With Use of Immunoglobulin G Avidity for Congenital Cytomegalovirus Infection.
Tanimura K; Tairaku S; Morioka I; Ozaki K; Nagamata S; Morizane M; Deguchi M; Ebina Y; Minematsu T; Yamada H
Clin Infect Dis; 2017 Oct; 65(10):1652-1658. PubMed ID: 29020153
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of CMV seroconversion in a Swiss pregnant women population.
Maine GT; Stricker R; Stricker R
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):275-7. PubMed ID: 22541330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]